Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

eMI Aesthetics vs Healthicare

eMI Aesthetics
Site position #119

Higher grade

Healthicare
Site position #242

Lower grade

The verdict

eMI Aesthetics takes it — 70.3/100 to 65.5/100.

eMI Aesthetics grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. eMI Aesthetics is a US direct-to-consumer telehealth brand offering doctor-guided GLP-1 weight loss programs to eligible patients in all 50 states.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueeMI Aesthetics +15
73
58
Dose & formulationHealthicare +4
84
88
Clinical oversightHealthicare +1
70
71
Labs & monitoringHealthicare +2
51
53
FulfillmenteMI Aesthetics +15
77
62
Contract termseMI Aesthetics +8
55
47
eMI Aesthetics · top barHealthicare · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetriceMI AestheticsHealthicare
WeighScore70.3/10065.5/100
GradeCC
Site position#119#242
Semaglutide$179/mo (all doses, compounded)$174/mo (compounded)
TirzepatideNot disclosed$264/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
eMI Aesthetics

Site position #119 · C

Strengths

  • Available to eligible patients in all 50 states
  • Offers both semaglutide and tirzepatide, plus an oral semaglutide option
  • Intake and provider visits run through OpenLoop Health, an established telehealth network

Where it loses points

  • Full per-drug pricing is not shown before intake; only an 'as low as 179/month' starting rate is published
  • No fill pharmacy or named medical director is publicly listed
  • Support appears limited to email, with no phone number or hours published
Healthicare

Site position #242 · C

Strengths

  • Both compounded and full brand-name menu (Ozempic, Wegovy, Mounjaro, Zepbound) on one platform
  • Pharmacy partner named publicly: Jungle Jim's Pharmacy (F&F Pharmacies Inc.), Fairfield, OH
  • Clinical lead named publicly: Dr. Jonah Mink, Beluga Health
  • Compounded semaglutide from $147.90/mo on the 3-month plan ($174/mo billed monthly) — lower end of the segment

Where it loses points

  • Not available in several states including CA, NV, NJ, NC, TX, MA — verify your state first
  • Brand-name first-month pricing of $1,199.99–$1,299.99 is at or above cash retail; value is on the compounded tier
  • Footer references 'Sunshine Health Studios Inc.' — relationship to the domain owner is unclear

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard